Once-daily dose of budesonide aqueous nasal spray 128 g is efficacious primary treatment with rapid onset in nasal polyps.

被引：0

作者：

Jankowski, R ^{[1
]}

Bonfils, P ^{[1
]}

Castillo, L ^{[1
]}

Gilain, L ^{[1
]}

Prades, JM ^{[1
]}

Strunski, V ^{[1
]}

机构：

[1] Hop Cent, Nancy, France

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1999年 / 103卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

635

引用

页码：S166 / S166

页数：1

共 43 条

[31] Fluticasone furoate nasal spray (FFNS) 110Gμ once-daily is effective in seasonal allergic rhinitis (SAR) caused by grass pollen
Fokkens, W.
Jogi, R.
Sidorenko, I.
Sitkauskiene, B.
van Tongeren, J.
Faris, M.
Ellsworth, A.
Caldwell, M.
ALLERGY, 2007, 62 : 134 - 134
[32] Long-term safety of fluticasone furoate nasal spray (FFNS) 110 μg once-daily in adults and adolescents with perennial allergic rhinitis
Rosenblut, A.
Bardin, P.
Fokkens, W.
Faris, M.
Wu, W.
Caldwell, M.
Rinia, B.
ALLERGY, 2007, 62 : 227 - 227
[33] LACK OF HYPOTHALAMIC-PITUITARY-ADRENAL AXIS SUPPRESSION WITH ONCE-DAILY OR TWICE-DAILY BECLOMETHASONE DIPROPIONATE AQUEOUS NASAL SPRAY ADMINISTERED TO PATIENTS WITH ALLERGIC RHINITIS
BRANNAN, MD
HERRON, JM
REIDENBERG, P
AFFRIME, MB
CLINICAL THERAPEUTICS, 1995, 17 (04) : 637 - 647
[34] Once-daily fluticasone furoate* nasal spray (FFNS) is effective for the treatment of seasonal allergic rhinitis (SAR) caused by ragweed *LISAN-approved name
Kaiser, H. B.
Naclerio, R.
Given, J.
Philpot, E.
Toler, T.
Ellsworth, A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S232 - S232
[35] Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily and twice daily in the treatment of bilateral nasal polyposis:: a placebo-controlled randomized study in adult patients
Penttilä, M
Poulsen, P
Hollingworth, K
Holmström, M
CLINICAL AND EXPERIMENTAL ALLERGY, 2000, 30 (01): : 94 - 102
[36] Efficacy and safety of triamcinolone acetonide aqueous nasal spray 110 μg once daily in children aged 2-5 years with perennial allergic rhinitis
Weinstein, S. F.
Georges, G.
Qaqundah, P.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A89 - A89
[37] Efficacy of a novel enhanced-affinity glucocorticoid on ocular symptoms, fluticasone furoate nasal spray (FFNS) 110 μg once-daily, in grass pollen-sensitive patients
Sidorenko, I.
Sitkauskiene, B.
Jogi, R.
Fokkens, W.
van Tongeren, J.
Faris, M.
Ellsworth, A.
Caldwell, M.
ALLERGY, 2007, 62 : 134 - 135
[38] The effect on growth of 6 month's treatment with triamcinolone acetonide aqueous nasal spray 110 μg once daily in children aged 2-5 years with perennial allergic rhinitis
Ratner, P.
Georges, G.
Kerwin, E.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S56 - S56
[39] Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis
R. Giger
P. Pasche
C. Cheseaux
L. Cantini
A. Rossetti
B. Landis
J. Lacroix
European Archives of Oto-Rhino-Laryngology, 2003, 260 : 135 - 140
[40] Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis
Giger, R
Pasche, P
Cheseaux, C
Cantini, L
Rossetti, A
Landis, BN
Lacroix, JS
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (03) : 135 - 140

← 1 2 3 4 5 →